Many Employees Misunderstand Online Vision Screenings, New Survey Shows

By Staff
Friday, September 20, 2019 12:30 AM PINELLAS PARK, Fla.—Many people have misunderstandings about online vision screenings, according to newly released research from Transitions Optical and the American Optometric Association (AOA). Half of respondents polled in the Transitions Employee Perceptions of Vision Benefits survey think that online vision screenings that provide a prescription are a suitable replacement for in-office eye exams. Millennials were the most likely to agree (57 percent)—compared to half of Gen Z, Gen X and 36 percent of Boomers. The AOA points out that online vision screenings are “no substitute for an in-person, comprehensive eye exam by an optometrist.” Aside from correcting vision, comprehensive eye exams can detect a number of vision problems, eye diseases and overall health issues that online eye exams cannot—including glaucoma, high blood pressure and diabetes.

Wize Pharma Licenses Ophthalmic Non-viral Gene Therapy Technology

By Staff
Friday, September 13, 2019 12:15 AM
HOD HASHARON, Israel—Wize Pharma a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, has entered into an exclusive license agreement with U.S.-based Copernicus Therapeutics. The agreement grants Wize exclusive rights to license, develop and commercialize products based on a non-viral gene therapy technology developed by Copernicus for the treatment of choroideremia (CHM). "We are very pleased and excited to enter into this agreement with Copernicus. Their proprietary and innovative technology addresses what we believe to be the greatest challenges in gene therapy, including overcoming the potential immune system response to treatment, thereby allowing repeated treatments if necessary. As an ophthalmology focused company, Wize is eager to develop and commercialize this cutting-edge gene therapy to transform the treatment of eye related diseases," said Mark Sieczkarek, chairman of the board of directors of Wize.

Allyala Nandakumar and Serge Resnikoff Join Vision Impact’s Institute’s Advisory Board

By Staff
Thursday, September 12, 2019 12:18 AM The Vision Impact Institute (VII) announced two new additions to its global advisory board. Allyala Nandakumar, PhD, and Serge Resnikoff, MD, PhD, were approved as board members at the organization's meeting in July. Dr. Nandakumar brings his expertise as an internationally recognized health-financing expert to the board. Currently, he is Professor of the Practice at Brandeis University where he is the director of the master of science program in global health and development. In January 2018, Nandakumar was appointed the first chief economist at the office of the global AIDS coordinator at the U.S. Department of State. He served previously as the chief economist for the Global Health Bureau at USAID.

New Career Zone to Offer Full Day of Networking Events at Expo West

By Staff
Thursday, September 12, 2019 12:15 AM ALEXANDRIA, Va.—Available at Vision Expo West on Saturday, Sept. 21, only, the new Career Zone will offer an environment designed to connect corporate optical companies and associations with potential hires. “Following its success at Vision Expo East, the Career Zone will provide attendees a comfortable location to explore career and leadership opportunities from a variety of well-respected businesses,” said Joanne Mohr, Vision Expo event director of Reed Exhibitions. “Attendees can take advantage of unique access to discussions focused on career resources and hiring advice that could transform their professional endeavors.”

Review of Myopia Management Launches Updated Website Design

By Staff
Wednesday, September 11, 2019 12:15 AM NEW YORK—The September edition of Review of Myopia Management features the launch of an upgraded website design that provides easier access to its multichannel content. “Review of Myopia Management, the first and only publication dedicated to myopia, has received amazing feedback since its inception in March 2019. However, we’ve heard that sometimes the website was difficult to navigate. With the launch of our redesigned website, we’ve now made it intuitive for eyecare professionals to find the exact content they are looking for,” said Dwight Akerman OD, MBA, FAAO, chief medical editor of Review of Myopia Management.

BHVI Embarks on a New Program for Growth

By Staff
Tuesday, September 10, 2019 12:18 AM SYDNEY, Australia — Brien Holden Vision Institute (BHVI) announced that it is embarking on a new strategic roadmap, a process that included realigning its organizational structure. As part of the realignment, Dr. Arthur Back has been appointed managing director of VisionCRC, BHVI’s science arm which translates the organization’s research into commercial products. "We are excited to have Dr. Arthur Back join us. Dr Back invented more than 60 patents and commercialized 18 products while he was chief technology officer at CooperVision. Combined with the expertise of Professor Sankaridurg, a pioneer in the field of Myopia research, we are at the forefront of our industry,” said Yvette Waddell, CEO of BHVI.

Review of Myopia Management Launches Updated Website Design

By Staff
Tuesday, September 10, 2019 12:15 AM NEW YORK—The September edition of Review of Myopia Management features the launch of an upgraded website design that provides easier access to its multichannel content. “Review of Myopia Management, the first and only publication dedicated to myopia, has received amazing feedback since its inception in March 2019. However, we’ve heard that sometimes the website was difficult to navigate. With the launch of our redesigned website, we’ve now made it intuitive for eyecare professionals to find the exact content they are looking for,” said Dwight Akerman OD, MBA, FAAO, chief medical editor of Review of Myopia Management.

Prevent Blindness Asks Kids, Adults to Make Eye Protection Part of the Uniform While Playing Sports

By Staff
Wednesday, August 28, 2019 12:24 AM CHICAGO—Prevent Blindness, the nation’s oldest non-profit eye health organization, has declared September as Sports Eye Safety Month to help educate the public on the best ways to keep eyes healthy while playing sports. For those who wear prescription glasses, an eye doctor can provide a prescription for safe and effective sports protective eyewear. Monocular athletes (those with only one eye that sees well) should consult an eye doctor about what sports are safe to participate in.

Vision Care Advocacy: A View of the Americas

By Andrew Karp
Monday, August 26, 2019 8:00 AM The Vision Impact Institute recently published an interview on its website that VII director Kristan Gross conducted with Judith Marcano Williams, VII Program Manager, The Americas. They discuss the unique challenges and opportunities that exist in the Americas pursuing the organization’s global mission: raising awareness about the importance of vision correction and making good vision a priority. 

Here are excerpts from their conversation: 

Williams: In a snapshot, there are 36 countries, more than one billion people, and more than 40 languages spoken. There are stigmas around vision care, especially for girls and women, and significant economic disparities. With multiple country and state governments regulating topics related to vision care, the region holds a vast opportunity to improve vision health policies.

VOSH Announces Annual Meeting With Animated Promotional Video

By Staff
Friday, August 23, 2019 12:10 AM ORLANDO, Fla.—The Volunteer Optometric Services to Humanity (VOSH) has announced its annual meeting for 2019. The meeting will take place on Oct. 27, 2019, in Orlando, Florida, and this year’s theme is “BIG VISION, small world.” This will mark the 27th annual VOSH meeting, where VOSH members and partners can participate in a day of learning, networking, and discussion. The meeting occurs during the World Council of Optometry (WCO) and the American Academy of Optometry’s 3rd World Congress of Optometry in Orlando from Oct. 23 to 28, 2019.

Myopia Experts Offer One-Day CE Course

By Staff
Tuesday, August 20, 2019 12:15 AM
NEW YORK—World renowned experts in myopia management will take an in-depth look at this timely and topical area of vision care during a one-day educational program for clinicians. Hosted by Gary Gerber, OD, co-founder of Treehouse eyes, The Myopia Meeting is scheduled to be held in Newport Beach, Calif. on Sunday, Oct. 6, 2019 from 7:30 a.m. to 5:00 p.m. Pacific Time. The meeting’s six hours of continuing education will be delivered by the following presenters:

FDA Approves Eylea Injection Prefilled Syringe

By Staff
Wednesday, August 14, 2019 12:18 AM TARRYTOWN, N.Y.—Regeneron Pharmaceuticals announced Tuesday that the U.S. Food and Drug Administration (FDA) has approved the Chemistry, Manufacturing and Controls (CMC) Prior-Approval Supplement (PAS) for its Eylea (aflibercept) injection prefilled syringe. The 2 mg, single-dose, sterilized prefilled syringe provides physicians with a new way to administer Eylea that requires fewer preparation steps compared to vials. Market supply of the Eylea prefilled syringe is expected to be available to physicians and patients this year, the company said in a statement.

Visioneering Secures Regulatory Registration in Hong Kong

By Staff
Wednesday, August 14, 2019 12:15 AM ATLANTA—Visioneering Technologies, based here, has received a Certificate of Listing from Hong Kong’s Medical Device Control Office, Department of Health. Listing No. 190176 applies to the NaturalVue (etafilcon A) Multifocal and NaturalVue (etafilcon A) Sphere currently marketed by Visioneering, as well as the NaturalVue (etafilcon A) Toric and NaturalVue (etafilcon A) Multifocal Toric products that Visioneering plans to market in the near future. The registration covers the use of the company’s NaturalVue Multifocal for myopia progression control.

Philanthropist Pledges $2 Million Gift to Combat Corneal Blindness

By Staff
Tuesday, July 30, 2019 12:18 AM LONDON and BOSTON—Tej Kohli, a London-based billionaire who made his fortune during the dotcom boom selling e-commerce payments software, has pledged $2 million to Massachusetts Eye and Ear in Boston to fund innovation in research to cure corneal blindness, including the development of promising biotechnology solutions. The move reflects Kohli’s belief in the promise of new technologies to build a better world as he seeks to find a solution to eliminating avoidable corneal blindness that is not dependent on transplantation.

Prevent Blindness and the NOA Name August Children’s Eye Health and Safety Month

By Staff
Thursday, July 25, 2019 12:24 AM CHICAGO—For the second year in a row, Prevent Blindness and the National Optometric Association have declared August Children’s Eye Health and Safety Awareness Month. As children and parents gear up for the back to school season, Prevent Blindness and NOA aim to educate parents and caregivers on what steps they can take to ensure that their children and students are getting the eyecare they need. 2019 also marks the 10th anniversary of the National Center for Children’s Vision and Eye Health at Prevent Blindness.